FDA Drug recall D-1269-2014
Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical In…
- FDA Drug
- Class I
- terminated
- Published 2014-05-07
On 2014-05-07 the FDA classified a Class I recall of Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical In… by B Braun Medical, citing presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1269-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-11-21 |
| Published | 2014-05-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | B Braun Medical |
| Distribution | US |
Product
Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical Inc., Irvine CA 92614, NDC 0264-3105-11
Reason
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Identifiers
| ndc | 0264-3103-11 |
|---|---|
| ndc | 0264-3105-11 |
| ndc | 0264-3107-11 |
| code_info | Lot# H2S723, Exp 07/14; H3H711, Exp 01/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1269-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.